Brief: Spectral Medical Provides Update On Tigris Clinical Trial
20/07/2022 14:48
July 20 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL PROVIDES UPDATE ON TIGRIS CLINICAL TRIAL
* SPECTRAL MEDICAL INC - PROVIDES POSITIVE CASE STUDY ON
PATIENT
ENROLLED AT UNIVERSITY OF MICHIGAN
* SPECTRAL MEDICAL INC - 14 CLINICAL SITES ACTIVELY
ENROLLING
PATIENTS WITH 40 PATIENTS NOW RANDOMIZED
* SPECTRAL MEDICAL INC - RECRUITMENT FOR TRIAL STEADILY
RISING
WITH 14 TRIAL SITES ACTIVELY SCREENING PATIENTS AND OPEN FOR
ENROLLMENT
Source text for Eikon: ID:nGNX9qPS40
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%